Metformin
Diabetes medication showing promise for aging and healthspan extension in research studies
Human Trials
47
8,420 participants
Risk Level
Monthly Cost
Generic versions widely available
Quick Facts
- Category
- Pharmaceutical
- Research Field
- Pharmacology
- Evidence Grade
- B+ – Good
- Risk Level
- Medium
- Monthly Cost
- $4 – $25
- Human Trials
- 47
Typical Dose
500 mg twice daily (1000 mg/day)
Range
500–2000 mg/day in divided doses
For informational purposes only – not medical advice. See disclaimer
Research Velocity
Mechanism of Action
Metformin activates AMP-activated protein kinase (AMPK), a key cellular energy sensor that regulates metabolism and aging pathways. It inhibits complex I of the mitochondrial respiratory chain and reduces hepatic glucose production. Research indicates these mechanisms may influence cellular aging processes, autophagy, and stress resistance pathways associated with longevity.
Overview
**Metformin is a widely prescribed diabetes medication that has garnered significant attention in longevity research for its potential anti-aging properties.** Originally derived from the French lilac plant, metformin works primarily by activating AMPK, a cellular energy sensor that plays crucial roles in metabolism and aging. Studies suggest that this mechanism may extend beyond glucose control to influence fundamental aging processes, including cellular stress resistance, autophagy, and mitochondrial function.
**Research indicates that metformin users may experience reduced incidence of age-related diseases including cardiovascular disease, certain cancers, and cognitive decline.** Large observational studies have shown associations with increased healthspan and potentially extended lifespan in diabetic populations. The landmark TAME (Targeting Aging with Metformin) clinical trial, currently in development, aims to test metformin specifically as an anti-aging intervention in non-diabetic older adults, which could provide definitive evidence for its longevity benefits.
**While generally well-tolerated, metformin requires medical supervision due to potential side effects including gastrointestinal issues and rare but serious lactic acidosis.** The medication may also affect vitamin B12 levels with long-term use. Current research focuses on optimal dosing for longevity benefits, with studies typically using 500-2000mg daily. As a prescription medication, metformin use for anti-aging purposes represents an off-label application that should be carefully considered with healthcare providers.
Known Interactions
- May increase risk of lactic acidosis when combined with alcohol or contrast dyes
- Can enhance hypoglycemic effects when used with other diabetes medications
- May reduce vitamin B12 absorption with long-term use
- Potential interactions with blood pressure medications and diuretics
Legal Status by Country
Your country (United States)
📍 = your selected country · ✈️ = medical tourism destination · Always verify current local regulations before travel.
Key Research
- 2019
Comprehensive review of metformin's effects on aging processes
- 2019
Large observational study on cancer outcomes
- 2018
Preclinical longevity study
- 2015
Mechanistic review of anti-aging properties
- 2022Targeting aging with metformin (TAME) trial design
Upcoming clinical trial protocol for aging intervention
Related Interventions
17-alpha-Estradiol
Research suggests this estrogen stereoisomer may extend lifespan in male mice while avoiding feminizing effects.
Acarbose
An alpha-glucosidase inhibitor showing potential longevity benefits through metabolic modulation and caloric restriction mimetics.
Low-Dose Aspirin
Well-studied anti-platelet therapy with extensive evidence for cardiovascular protection and potential longevity benefits.
BPC-157
Synthetic peptide derived from gastric juice showing promise for tissue repair and wound healing in animal studies.
Last verified: 2026-03-16